NSYS Nortech Systems Inc.

Nortech Systems Reports First Quarter Results

Nortech Systems Reports First Quarter Results

MINNEAPOLIS, May 14, 2025 (GLOBE NEWSWIRE) -- Nortech Systems Incorporated (Nasdaq: NSYS) (“Nortech” or the “Company”), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical imaging, medical device, industrial and aerospace & defense markets, reported financial results for the first quarter ended March 31, 2025.

2025 Q1 Highlights:

 Net sales of $26.9 million
 Net loss of ($1.3) million, or ($0.48) per diluted share
 Adjusted earnings before interest, taxes, depreciation, and amortization (“EBITDA”) of ($1.0) million loss
 90-day backlog of $26.7 million as of March 31, 2025
   

Management Commentary

“Over the past few quarters, we have successfully transitioned and stabilized our business, allowing for smoother operational flow and setting a solid foundation for future growth. Nortech has taken steps to consolidate our operations to focus on driving profitability and growth within our core market segments. These strategic moves are designed to better scale the business, improve efficiency, and reduce our ongoing cost structure.” said Jay D. Miller, President and CEO. “We made tough decisions that have depressed our short-term revenues and EBITDA but have strategically positioned the Company for long-term growth and innovation specifically in the aerospace & defense and medical imaging markets.”

“The Company experienced delays in our defense customers’ approvals for transfers from our closed Blue Earth facility to our Bemidji plant, and those transfers continue to progress steadily. We continue to anticipate clearing the majority of this approval backlog during the second quarter of 2025. Additionally, our research and development programs, particularly in fiber optic technologies, reflect our commitment to provide customers with technologies that are lighter, faster and more sustainable. This commitment has been evident by the issuance of two new patents in the past year,” Miller added.

“We continue to be impressed by the dedication and collaboration demonstrated by our employees across all locations to do the hard work necessary to achieve our goals. The team’s unwavering commitment enables us to overcome challenges and embrace innovation,” Miller said.

“We’re also closely following changes in regulations, trade policies, and geopolitical factors for potential impacts in our key market segments. We believe the strategic repositioning of our global operations in the past year has further strengthened the Company’s ability to respond to our customers’ needs to near-shore their supply chains. We are well-prepared to shift production closer to key markets, improving efficiency and strengthening our ability to handle global challenges and uncertainties.”

Summary Financial Information

The following table provides summary financial information comparing the first quarter 2025 (“Q1 2025”) financial results to the same quarter in 2024 (“Q1 2024”).

($ in thousands) Q1 2025  Q1 2024  % Change 
Net sales $26,895  $34,215   (21.4)%
Gross profit $3,078  $5,448   (43.5)%
Operating expenses $4,691  $4,293   9.3%
Net (loss) income $(1,316) $765   (272.0)%
EBITDA $(1,266) $1,637   (177.3)%
Adjusted EBITDA $(1,000) $1,637   (161.1)%
             

Conference Call

The Company will hold a live conference call and webcast at 3:30 p.m. central time on Wednesday, May 14, to discuss the Company’s 2025 first quarter results. The call will be hosted by Jay D. Miller, Chief Executive Officer and President and Andrew D. C. LaFrence, Chief Financial Officer. To access the live audio conference call, US participants may call 888-506-0062 and international participants may call 973-528-0011. Participant Access Code: 830813. Participants may also access the call via webcast at: .

###

About Nortech Systems Incorporated

Nortech Systems is a leading provider of design and manufacturing solutions for complex electromedical devices, electromechanical systems, assemblies, and components. Nortech primarily serves the medical imaging, medical device, aerospace & defense, and industrial markets. Its design services span concept development to commercial design, and include medical device, software, electrical, mechanical, and biomedical engineering. Its manufacturing and supply chain capabilities are vertically integrated around wire, cable, and interconnect assemblies, printed circuit board assemblies, as well as system-level assembly, integration, and final test. Headquartered in Maple Grove, Minn., Nortech currently has six manufacturing locations and design centers across the U.S., Latin America, and Asia. Nortech Systems is traded on the NASDAQ Stock Market under the symbol NSYS. Nortech’s website is .

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 including without limitation statements regarding future financial results, gaining approval of customers relating to moving production from one facility to another Company-owned facility, strengthening of customer relationships, achieving long-term strategic goals, effects of restructuring and consolidating manufacturing facilities, sustained long-term health and growth, ability to scale our business, reducing cost structure and optimism about customer pipeline. While this release is based on management’s best judgment and current expectations, actual results may differ materially from those expressed or implied and involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from the forward-looking statements include, without limitation: (1) commodity cost increases coupled with challenges in raising prices and/or customer pressure to reduce prices; (2) supply chain disruptions leading to shortages of critical components; (3) volatility in market conditions which may affect demand for the Company’s products; (4) increased competition and/or reduced demand; (5) changes in the reliability and efficiency of operating facilities or those of third parties; (6) risks related to the availability of labor; (7) the unanticipated loss of any key member of senior management; (8) geopolitical, economic, financial and business conditions; (9) the Company’s ability to steadily improve manufacturing output and product quality; (10) the impact of global health epidemics on our customers, employees, manufacturing facilities, suppliers, the capital markets and our financial condition; or (11) challenges with customers with respect to moving production from one facility to another Company-owned facility. Some of the above-mentioned factors are described in further detail in the section entitled “Risk Factors” in our annual and quarterly reports, as applicable. You should assume the information appearing in this document is accurate only as of the date hereof, or as otherwise specified, as our business, financial condition, results of operations and prospects may have changed since such date. Except as required by applicable law, including the securities laws of the United States and the rules and regulations of the United States Securities and Exchange Commission, we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, to reflect actual results or changes in factors or assumptions affecting such forward-looking statements.

Reconciliation of Generally Accepted Accounting Principles (“GAAP”) Measures to Non-GAAP Financial Measure

EBITDA is a non-GAAP financial measure used by management that we believe provides useful information to investors because it reflects ongoing performance excluding certain non-recurring items during comparable periods and facilitates comparisons between peer companies since interest, taxes, depreciation, and amortization can differ greatly between different organizations as a result of differing capital structures and tax strategies. EBITDA is defined as net income (loss) plus interest expense, plus income tax expense plus depreciation expense and amortization expense. EBITDA should be considered in addition to, not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. Adjusted EBITDA reflects the impact of restructuring and non-recurring items. EBITDA and Adjusted EBITDA are not a measurement of our financial performance under GAAP and should not be considered an alternative to net sales or net income (loss), as applicable, or any other performance measures derived in accordance with GAAP and may not be comparable to other similarly titled measures of other businesses. EBITDA and Adjusted EBITDA have limitations as an analytical metric, and you should not consider it in isolation or as a substitute for analysis of our operating results as reported under GAAP.

NORTECH SYSTEMS INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

AND COMPREHENSIVE (LOSS) INCOME

(UNAUDITED)

(IN THOUSANDS, EXCEPT SHARE DATA)

  THREE MONTHS ENDED 
  MARCH 31, 
  2025  2024 
       
Net sales $26,895  $34,215 
Cost of goods sold  23,817   28,767 
Gross profit  3,078   5,448 
Operating expenses        
Selling  1,184   805 
General and administrative  2,915   3,170 
Research and development  326   318 
Restructuring charges  266   - 
Total operating expenses  4,691   4,293 
(Loss) income from operations  (1,613)  1,155 
Other expense        
Interest expense  (214)  (167)
(Loss) income before income taxes  (1,827)  988 
Income tax (benefit) expense  (511)  223 
Net (loss) income $(1,316) $765 
         
Net (loss) income per common share:        
Basic (in dollars per share) $(0.48) $0.28 
Weighted average number of common shares outstanding - basic (in shares)  2,760,929   2,742,511 
Diluted (in dollars per share) $(0.48) $0.26 
Weighted average number of common shares outstanding - diluted (in shares)  2,760,929   2,908,457 
         
Other comprehensive (loss) income        
Foreign currency translation  6   (183)
Comprehensive (loss) income, net of tax $(1,310) $582 



NORTECH SYSTEMS INCORPORATED AND SUBSIDIARIES


CONDENSED CONSOLIDATED BALANCE SHEETS

AS OF MARCH 31, 2025 AND DECEMBER 31, 2024

(UNAUDITED)

(IN THOUSANDS, EXCEPT SHARE DATA)

  MARCH 31, 2025  DECEMBER 31, 2024 
ASSETS        
Current assets:        
Cash $1,162  $916 
Accounts receivable, less allowances of $231 and $196, respectively  15,668   14,875 
Inventories, net  20,910   21,638 
Contract assets  13,404   13,792 
Assets held for sale  507   - 
Prepaid assets and other assets  5,673   4,094 
Total current assets  57,324   55,315 
Property and equipment, net  5,575   6,232 
Operating lease assets, net  7,831   8,139 
Deferred tax assets  2,575   2,575 
Other intangible assets, net  169   174 
Other assets  59   - 
Total assets $73,533  $72,435 
         
LIABILITIES AND SHAREHOLDERS’ EQUITY        
Current liabilities:        
Accounts payable $10,062  $11,582 
Accrued payroll and commissions  2,515   1,841 
Customer deposits  5,028   5,140 
Current portion of operating leases  1,187   1,175 
Current portion of finance lease obligations  121   143 
Notes payable  563   344 
Other accrued liabilities  1,240   1,203 
Total current liabilities  20,716   21,428 
Long-term liabilities:        
Long-term line of credit  11,955   8,634 
Long-term operating lease obligations, net of current portion  7,462   7,773 
Long-term finance lease obligations, net of current portion  281   311 
Other long-term liabilities  287   284 
Total long-term liabilities  19,985   17,002 
Total liabilities  40,701   38,430 
Shareholders’ equity:        
Preferred stock, $1 par value; 1,000,000 shares authorized; 250,000 shares issued and outstanding  250   250 
Common stock - $0.01 par value; 9,000,000 shares authorized; 2,760,993 and 2,760,793 shares issued and outstanding, respectively  28   28 
Additional paid-in capital  17,466   17,329 
Accumulated other comprehensive loss  (971)  (977)
Retained earnings  16,059   17,375 
Total shareholders’ equity  32,832   34,005 
Total liabilities and shareholders’ equity $73,533  $72,435 



NORTECH SYSTEMS INCORPORATED AND SUBSIDIARIES


CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

(IN THOUSANDS)

  THREE MONTHS ENDED

MARCH 31,
 
  2025  2024 
CASH FLOWS FROM OPERATING ACTIVITIES        
Net (loss) income $(1,316) $765 
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:        
Depreciation  342   442 
Amortization  5   40 
Compensation on stock-based awards  118   80 
Change in accounts receivable allowances  35   (66)
Change in inventory reserves  231   76 
Other, net  -   (4)
Changes in current operating assets and liabilities:        
Accounts receivable  (814)  3,215 
Inventories  487   (1,400)
Contract assets  388   287 
Prepaid expenses and other assets  (1,588)  (328)
Accounts payable  (1,441)  (8)
Accrued payroll and commissions  674   640 
Customer deposits  (112)  (926)
Other accrued liabilities  61   15 
Net cash (used in) provided by operating activities  (2,930)  2,828 
         
CASH FLOWS FROM INVESTING ACTIVITIES        
Proceeds from sale of property and equipment  -   9 
Purchases of property and equipment  (268)  (744)
Net cash used in investing activities  (268)  (735)
         
CASH FLOWS FROM FINANCING ACTIVITIES        
Proceeds from line of credit  25,970   32,768 
Payments to line of credit  (22,710)  (32,394)
Proceeds from notes payable  219   - 
Principal payments on financing leases  (52)  (100)
Stock option exercises  19   - 
Net cash provided by financing activities  3,446   274 
         
Effect of exchange rate changes on cash  (2)  (14)
         
Net change in cash  246   2,353 
Cash - beginning of period  916   1,675 
Cash - end of period $1,162  $4,028 



  THREE MONTHS ENDED

MARCH 31,
 
  2025  2024 
RECONCILIATION OF NET (LOSS) INCOME TO EBITDA        
($ in thousands)        
Net (loss) income $(1,316) $765 
Interest  214   167 
Taxes  (511)  223 
Depreciation  342   442 
Amortization  5   40 
EBITDA  (1,266)  1,637 
Restructuring charges  266   - 
ADJUSTED EBITDA $(1,000) $1,637 



There were no material adjustments to EBITDA in the quarter ended March 31, 2024.

Adjustment to EBITDA in the quarter ended March 31, 2025 includes ($ in thousands):

 In the second quarter of 2024, we announced the closure of our Blue Earth, Minnesota facility. In connection with activities related to the Blue Earth facility and additional staff reductions in the first quarter of 2025, we incurred $266 of restructuring charges in the quarter ended March 31, 2025, which expense amount is not included in Adjusted EBITDA.



($ in millions) Last Twelve Months (LTM) Ended in Quarter 
  Q1 2022  Q2 2022  Q3 2022  Q4 2022  Q1 2023  Q2 2023  Q3 2023  Q4 2023  Q1 2024  Q2 2024  Q3 2024  Q4 2024  Q1 2025 
Net Sales $123.8  $126.1  $132.0  $134.1  $138.3  $140.8  $138.9  $139.3  $138.7  $137.5  $135.6  $128.1  $120.8 
                                                     
Gross Profit $ - Adjusted  13.7   15.1   18.1   20.5   21.9   22.4   21.4   23.1   23.1   22.2   20.7   16.7   14.4 
Gross Margin % - Adjusted  11.0%  12.0%  13.7%  15.3%  15.8%  15.9%  15.4%  16.6%  16.6%  16.1%  14.9%  13.1%  11.9%
                                                     
EBITDA - Adjusted $1.9  $2.5  $4.2  $5.8  $6.7  $6.8  $6.0  $8.0  $8.1  $7.3  $5.9  $2.1  $(0.5)
                                                     

Contact

Andrew D. C. LaFrence

Chief Financial Officer and Senior Vice President of Finance



952-345-2243



EN
14/05/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Nortech Systems Inc.

 PRESS RELEASE

Nortech Systems Reports First Quarter Results

Nortech Systems Reports First Quarter Results MINNEAPOLIS, May 14, 2025 (GLOBE NEWSWIRE) -- Nortech Systems Incorporated (Nasdaq: NSYS) (“Nortech” or the “Company”), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical imaging, medical device, industrial and aerospace & defense markets, reported financial results for the first quarter ended March 31, 2025. 2025 Q1 Highlights:  ●Net sales of $26.9 million ●Net loss of ($1.3) million, or ($0.48) per diluted share ●Adjusted earnings before interest, taxes...

 PRESS RELEASE

Nortech Systems Incorporated to Report First Quarter 2025 Financial Re...

Nortech Systems Incorporated to Report First Quarter 2025 Financial Results and Hold a Conference Call on May 14, 2025 MINNEAPOLIS, May 09, 2025 (GLOBE NEWSWIRE) -- Nortech Systems Incorporated (Nasdaq: NSYS) (the “Company”), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical imaging, medical device, aerospace & defense and industrial markets, will hold a live conference call and webcast at 3:30 p.m. Central Time on Wednesday May 14, 2025, to discuss the Company's first quarter 2025 financial results....

 PRESS RELEASE

Nortech Systems Reports Fourth Quarter Results

Nortech Systems Reports Fourth Quarter Results MINNEAPOLIS, March 31, 2025 (GLOBE NEWSWIRE) -- Nortech Systems Incorporated (Nasdaq: NSYS) (“Nortech” or the “Company”), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical, industrial and defense markets, reported financial results for the fourth quarter ended December 31, 2024. 2024 Q4 Highlights:  ●Net sales of $28.6 million ●Net loss of ($1.5) million, or ($0.54) per diluted share ●Adjusted earnings before interest, taxes, depreciation, and amortizat...

 PRESS RELEASE

Nortech Systems Incorporated to Report Fourth Quarter 2024 Financial R...

Nortech Systems Incorporated to Report Fourth Quarter 2024 Financial Results and Hold a Conference Call on March 31, 2025 MINNEAPOLIS, March 25, 2025 (GLOBE NEWSWIRE) -- Nortech Systems Incorporated (Nasdaq: NSYS) (the “Company”), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical imaging, medical device, aerospace & defense and industrial markets, will hold a live conference call and webcast at 3:30 p.m. Central Time on Monday, March 31, 2025, to discuss the Company's fourth quarter and full year 202...

 PRESS RELEASE

Nortech Systems Reports Third Quarter Results

Nortech Systems Reports Third Quarter Results MINNEAPOLIS, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Nortech Systems Incorporated (Nasdaq: NSYS) (“Nortech” or the “Company”), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical, industrial and defense markets, reported financial results for the third quarter ended September 30, 2024. 2024 Q3 Highlights:  ●Net sales of $31.4 million ●Net loss of ($739) thousand, or ($0.27) per diluted share ●Adjusted earnings before interest, taxes, depreciation, and amor...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch